Position in GRFS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$84,535
-$9,892 QoQ
Shares Held
11,940
+1.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#102
of 164 holders
Holding Since
Dec 2025
3 quarters on record
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IEQ CAPITAL, LLC holds $481,023,906 across 15 Drug Manufacturers - General names. GRFS ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
106,721 | $128,004,379 | |
| 2 | MRK |
Merck & Co., Inc.
|
799,214 | $102,698,999 | |
| 3 | JNJ |
Johnson & Johnson
|
306,145 | $77,751,644 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
1,252,740 | $72,182,878 | |
| 5 | BIIB |
Biogen Inc.
|
132,142 | $28,550,600 | |
| 6 | ABBV |
AbbVie Inc.
|
102,081 | $25,687,662 | |
| 7 | PFE |
Pfizer Inc
|
742,927 | $17,889,681 | |
| 8 | NVS |
Novartis AG
|
43,358 | $6,795,065 |
All Filings in GRFS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $84,535 | 11,940 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $94,427 | 11,774 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $154,237 | 16,496 | Shares | Other | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||